Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
15.00
Dollar change
+0.04
Percentage change
0.27
%
IndexRUT P/E- EPS (ttm)-3.72 Insider Own17.38% Shs Outstand32.49M Perf Week0.40%
Market Cap511.80M Forward P/E- EPS next Y-1.93 Insider Trans-0.35% Shs Float28.19M Perf Month-17.45%
Income-102.24M PEG- EPS next Q-0.87 Inst Own72.01% Short Float15.08% Perf Quarter4.17%
Sales82.71M P/S6.19 EPS this Y-2.81% Inst Trans-0.56% Short Ratio12.17 Perf Half Y-0.60%
Book/sh-2.01 P/B- EPS next Y47.07% ROA-65.14% Short Interest4.25M Perf Year87.27%
Cash/sh4.04 P/C3.71 EPS next 5Y- ROE- 52W Range7.79 - 24.13 Perf YTD0.00%
Dividend Est.- P/FCF- EPS past 5Y5.89% ROI-299.11% 52W High-37.84% Beta1.07
Dividend TTM- Quick Ratio5.24 Sales past 5Y13144.25% Gross Margin88.68% 52W Low92.55% ATR (14)1.18
Dividend Ex-Date- Current Ratio5.42 EPS Y/Y TTM22.21% Oper. Margin-79.23% RSI (14)41.23 Volatility9.72% 7.50%
Employees201 Debt/Eq- Sales Y/Y TTM28.52% Profit Margin-123.61% Recom1.40 Target Price38.50
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q41.19% Payout- Rel Volume0.50 Prev Close14.96
Sales Surprise4.26% EPS Surprise-5.88% Sales Q/Q30.06% EarningsMar 14 BMO Avg Volume349.40K Price15.00
SMA20-8.97% SMA50-10.52% SMA2000.93% Trades Volume175,784 Change0.27%
Date Action Analyst Rating Change Price Target Change
Feb-08-23Downgrade Jefferies Buy → Hold $35 → $10
Apr-27-22Initiated Berenberg Buy $20
Apr-16-20Reiterated H.C. Wainwright Buy $53 → $57
Apr-13-20Reiterated H.C. Wainwright Buy $75 → $53
Jan-09-20Initiated National Securities Neutral $37
May-30-19Initiated JP Morgan Neutral
May-29-19Initiated Goldman Neutral
Jan-29-19Initiated H.C. Wainwright Buy $82
Nov-08-18Resumed Jefferies Buy
Apr-04-18Upgrade Raymond James Mkt Perform → Outperform
Mar-15-24 10:30AM
Mar-14-24 12:53PM
09:32AM
09:10AM
08:00AM
08:00AM Loading…
Mar-08-24 08:00AM
Mar-04-24 08:00AM
Feb-26-24 08:00AM
Feb-01-24 08:00AM
Jan-24-24 08:00AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Dec-08-23 04:00PM
Nov-15-23 01:50PM
Nov-14-23 12:19PM
08:00AM Loading…
08:00AM
Nov-13-23 08:00AM
Nov-07-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 07:00AM
Sep-08-23 08:00AM
Aug-31-23 08:00AM
Aug-18-23 01:40PM
Aug-17-23 07:00AM
Aug-12-23 09:18AM
Aug-10-23 09:55AM
09:15AM
08:00AM
Aug-08-23 08:00AM
Aug-02-23 05:00PM
10:05AM Loading…
Aug-01-23 10:05AM
Jul-31-23 08:00AM
Jul-28-23 01:41PM
Jul-27-23 09:55AM
09:50AM
Jul-25-23 04:10PM
Jul-10-23 08:00AM
Jul-06-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 08:00AM
Jun-02-23 08:00AM
May-22-23 01:18PM
May-16-23 12:13PM
May-11-23 09:15AM
08:00AM
May-04-23 08:00AM
May-02-23 10:02AM
May-01-23 02:00PM
Apr-30-23 08:00AM
Apr-25-23 08:00AM
Apr-18-23 12:16PM
Mar-18-23 02:06AM
Mar-16-23 09:15AM
08:00AM
Mar-09-23 04:00PM
Mar-06-23 08:00AM
Mar-01-23 04:00PM
Feb-27-23 08:15AM
Feb-15-23 09:06AM
Feb-06-23 05:33AM
Jan-11-23 08:00AM
Jan-09-23 12:19PM
Dec-19-22 08:00AM
Dec-13-22 12:13PM
Dec-09-22 08:00AM
Dec-02-22 12:00PM
Dec-01-22 07:00PM
Nov-21-22 04:00PM
Nov-16-22 11:24AM
Nov-14-22 08:00AM
Nov-12-22 07:33AM
Nov-10-22 09:15AM
08:00AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-12-22 04:29AM
Oct-11-22 11:54AM
08:00AM
Sep-28-22 08:00AM
Sep-12-22 08:00AM
Sep-09-22 08:00AM
Sep-07-22 04:00PM
Aug-11-22 09:15AM
08:00AM
Jul-27-22 08:00AM
Jul-24-22 09:56AM
Jul-12-22 09:05AM
Jun-09-22 09:07AM
Jun-03-22 08:00AM
May-18-22 08:00AM
May-16-22 02:50PM
May-13-22 08:00AM
May-10-22 10:15AM
09:00AM
08:00AM
May-09-22 06:15PM
May-05-22 06:35PM
May-03-22 08:00AM
Mar-29-22 08:00AM
Mar-22-22 08:02AM
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoenberg MarkChief Medical OfficerMar 18 '24Sale14.0512,000168,600139,437Mar 20 04:38 PM
Smith Jason DrewGeneral CounselJan 31 '24Sale15.744,99378,59018,824Feb 02 07:12 PM
Schoenberg MarkChief Medical OfficerJan 31 '24Sale15.743,78959,639149,423Feb 02 07:07 PM
Smith Jason DrewGeneral CounselAug 31 '23Sale18.013,80068,43818,407Sep 05 04:28 PM